Healthcare Triangle (HCTI) EBITDA (2020 - 2026)

Healthcare Triangle (HCTI) has 7 years of EBITDA data on file, last reported at -$3.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA fell 159.16% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$12.0 million (down 170.57% YoY), and the FY2025 full-year result was -$9.8 million, down 106.04% from the prior year.
• EBITDA rose to -$3.6 million in Q1 2026, from -$4.4 million in the prior quarter.
• In the past five years, EBITDA ranged from a high of -$498000.0 in Q4 2024 to a low of -$10.7 million in Q4 2022.
• A 5-year average of -$2.5 million and a median of -$1.6 million in 2023 frame the typical range for EBITDA.
• Across the five-year window, EBITDA soared 87.19% in 2023 and plunged 792.17% in 2025, its largest moves.
• Tracing HCTI's EBITDA over 5 years: stood at -$10.7 million in 2022, then soared by 87.19% to -$1.4 million in 2023, then soared by 63.57% to -$498000.0 in 2024, then sank by 792.17% to -$4.4 million in 2025, then advanced by 18.46% to -$3.6 million in 2026.
• Business Quant data shows HCTI's EBITDA at -$3.6 million in Q1 2026, -$4.4 million in Q4 2025, and -$2.6 million in Q3 2025.